239 related articles for article (PubMed ID: 11289046)
1. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.
Boden G; Chen X; Capulong E; Mozzoli M
Diabetes; 2001 Apr; 50(4):810-6. PubMed ID: 11289046
[TBL] [Abstract][Full Text] [Related]
2. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
Roden M; Stingl H; Chandramouli V; Schumann WC; Hofer A; Landau BR; Nowotny P; Waldhäusl W; Shulman GI
Diabetes; 2000 May; 49(5):701-7. PubMed ID: 10905476
[TBL] [Abstract][Full Text] [Related]
3. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
5. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
Boden G; Chen X; Stein TP
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E23-30. PubMed ID: 11120655
[TBL] [Abstract][Full Text] [Related]
6. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.
Chen X; Iqbal N; Boden G
J Clin Invest; 1999 Feb; 103(3):365-72. PubMed ID: 9927497
[TBL] [Abstract][Full Text] [Related]
7. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
Gastaldelli A; Toschi E; Pettiti M; Frascerra S; Quiñones-Galvan A; Sironi AM; Natali A; Ferrannini E
Diabetes; 2001 Aug; 50(8):1807-12. PubMed ID: 11473042
[TBL] [Abstract][Full Text] [Related]
8. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
Gastaldelli A; Baldi S; Pettiti M; Toschi E; Camastra S; Natali A; Landau BR; Ferrannini E
Diabetes; 2000 Aug; 49(8):1367-73. PubMed ID: 10923639
[TBL] [Abstract][Full Text] [Related]
9. Gluconeogenesis and glycogenolysis in health and diabetes.
Boden G
J Investig Med; 2004 Sep; 52(6):375-8. PubMed ID: 15612450
[TBL] [Abstract][Full Text] [Related]
10. The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus.
Clore JN; Allred J; White D; Li J; Stillman J
Metabolism; 2002 Nov; 51(11):1471-7. PubMed ID: 12404200
[TBL] [Abstract][Full Text] [Related]
11. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
12. The effect of pioglitazone on the liver: role of adiponectin.
Gastaldelli A; Miyazaki Y; Mahankali A; Berria R; Pettiti M; Buzzigoli E; Ferrannini E; DeFronzo RA
Diabetes Care; 2006 Oct; 29(10):2275-81. PubMed ID: 17003306
[TBL] [Abstract][Full Text] [Related]
13. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
Boden G; Chen X
Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
[TBL] [Abstract][Full Text] [Related]
14. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.
Perriello G; Pampanelli S; Del Sindaco P; Lalli C; Ciofetta M; Volpi E; Santeusanio F; Brunetti P; Bolli GB
Diabetes; 1997 Jun; 46(6):1010-6. PubMed ID: 9166673
[TBL] [Abstract][Full Text] [Related]
15. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type 1 diabetes.
Boden G; Cheung P; Homko C
Diabetes; 2003 Jan; 52(1):133-7. PubMed ID: 12502503
[TBL] [Abstract][Full Text] [Related]
17. Lipid-dependent control of hepatic glycogen stores in healthy humans.
Stingl H; Krssák M; Krebs M; Bischof MG; Nowotny P; Fürnsinn C; Shulman GI; Waldhäusl W; Roden M
Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
[TBL] [Abstract][Full Text] [Related]
18. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis.
Gastaldelli A; Miyazaki Y; Pettiti M; Buzzigoli E; Mahankali S; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 2004 Aug; 89(8):3914-21. PubMed ID: 15292327
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.
Kehlenbrink S; Tonelli J; Koppaka S; Chandramouli V; Hawkins M; Kishore P
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E165-73. PubMed ID: 19417129
[TBL] [Abstract][Full Text] [Related]
20. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance.
Woerle HJ; Popa E; Dostou J; Welle S; Gerich J; Meyer C
Metabolism; 2002 Nov; 51(11):1494-500. PubMed ID: 12404204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
